K. Dusenbury

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, J. Whangbo, 2019, Blood advances.

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

C. Ebens, S. Terezakis, V. Bachanova, 2022, medRxiv.